AVP and Hyperglycemia: These data, together with a Mendelian randomization study, in which genetic variation in the human vasopressin gene was recently associated with both elevated copeptin and increased risk for hyperglycemia in men, but not in women (15), supports causality between elevated copeptin and metabolic disease.